Evidence map›Paper›PMID 41565626›Full record

ArticleCell death & disease2026

Correction: Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing.

Francesca Barberini, Riccardo Pietroni, Simone Ielpo, Valeria Lucarini, Daniela Nardozi, Ombretta Melaiu, Monica Benvenuto, Chiara Focaccetti, Camilla Palumbo, Federica Rossin and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Francesca BarberiniDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Riccardo Pietroni *Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Simone Ielpo *Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Valeria LucariniDepartment of Experimental Medicine, University of Rome "Sapienza", Rome, Italy.
Daniela NardoziDepartment of Experimental Medicine, University of Rome "Sapienza", Rome, Italy.
Ombretta MelaiuDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Monica BenvenutoDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Chiara FocaccettiDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.ORCID http://orcid.org/0000-0002-7334-3966
Camilla PalumboDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Federica RossinDepartment of Biology, University of Rome "Tor Vergata", Rome, Italy.ORCID http://orcid.org/0000-0002-4313-8347
Doriana FruciBambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Daniel OliveImmunity and Cancer Team, Cancer Research Center of Marseille, CRCM, INSERM U1068, CNRS UMR7258, Aix-Marseille University U105, Marseille, France.
Laura MasuelliDepartment of Experimental Medicine, University of Rome "Sapienza", Rome, Italy.
Roberto BeiDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Loredana CifaldiDepartment of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy. cifaldi@med.uniroma2.it.ORCID http://orcid.org/0000-0001-5014-430X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41565626
PMCPMC12823555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.